Age, CD34+ cell dose, conditioning and pre-transplant cytopenias can help predict transfusion support in lymphoma patients undergoing autologous stem cell transplantation.
Isabel Regalado-ArtamendiMarta García-FasanellaLaura MedinaJesus Fernandez-SojoAlbert EsquirolGarcía-Cadenas IreneRodrigo Martino BofarullJavier BrionesSierra JorgeSilvana NovelliPublished in: Vox sanguinis (2023)
/kg and pre-transplant cytopenia and/or Day -10 to 0 transfusion) allowed dividing patients into three groups with significant differences between them regarding the time until transfusion independence.
Keyphrases
- stem cell transplantation
- cardiac surgery
- patients undergoing
- end stage renal disease
- high dose
- sickle cell disease
- ejection fraction
- cell therapy
- chronic kidney disease
- newly diagnosed
- bone marrow
- diffuse large b cell lymphoma
- peritoneal dialysis
- single cell
- acute kidney injury
- stem cells
- patient reported
- platelet rich plasma